ABBVIE INC. (ABBV)
Clinical trial NCT06536049 updates: 1. completion date: 2028-12-31 → 2027-10-31 2. primary completion date: 2026-12-31 → 2027-08-31
Clinical trial NCT06536049 updates: 1. completion date: 2028-12-31 → 2027-10-31 2. primary completion date: 2026-12-31 → 2027-08-31
📉 **NEGATIVE** • Medium confidence analysis (68%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical